CXCL13 and colorectal carcinoma: Similar results were obtained by Qi et al. [115], who also showed that the expression of CXCL13 and its receptor CXCR5 were significantly increased in CRC tissues compared with adjacent cancer cells, which was more apparent in tumors with higher tumor staging (T3 stage).